Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hataya K. Poonyagariyagorn"'
Autor:
Vincent Cottin, Nikhil A. Hirani, David L. Hotchkin, Anoop M. Nambiar, Takashi Ogura, María Otaola, Dirk Skowasch, Jong Sun Park, Hataya K. Poonyagariyagorn, Wim Wuyts, Athol U. Wells
Publikováno v:
European Respiratory Review, Vol 27, Iss 150 (2018)
Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated with worsening respiratory symptoms, lung function decline, limited
Externí odkaz:
https://doaj.org/article/7a3b048e30e34a06a74e12a5a72e396b
Autor:
Dirk Skowasch, Vincent Cottin, Athol U. Wells, Takashi Ogura, Jong Sun Park, Hataya K. Poonyagariyagorn, Maria Otaola, Wim A. Wuyts, David L. Hotchkin, Anoop M. Nambiar, Nikhil Hirani
Publikováno v:
Cottin, V, Hirani, N A, Hotchkin, D L, Nambiar, A M, Ogura, T, Otaola, M, Skowasch, D, Park, J S, Poonyagariyagorn, H K, Wuyts, W & Wells, A U 2018, ' Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases ', European Respiratory Review, vol. 27, no. 150, 180076 . https://doi.org/10.1183/16000617.0076-2018
European Respiratory Review, Vol 27, Iss 150 (2018)
European Respiratory Review, Vol 27, Iss 150 (2018)
Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated with worsening respiratory symptoms, lung function decline, limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fadd2629e2f1ff09fc21fead79156e3f
https://pubmed.ncbi.nlm.nih.gov/30578335
https://pubmed.ncbi.nlm.nih.gov/30578335
Autor:
Elinor L. Sullivan, Charles E. Roselli, Hataya K. Poonyagariyagorn, Teri L. Wadsworth, Dennis R. Koop
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 306:187-194
PC-SPES, a proprietary mixture composed of eight different herbs, is used worldwide as an alternative treatment by prostate cancer patients. It has been suggested that the clinical and in vitro antitumor activity exhibited by PC-SPES may be due to es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abef940de298a8480ab1f19403812400
https://doi.org/10.1124/jpet.102.048645
https://doi.org/10.1124/jpet.102.048645